Defiance Daily Target 2X Long HIMS ETF (HIMZ)

HIMZ is a leveraged exchange-traded fund that tracks Teladoc’s HIMS stock with daily 2X amplification. It exists to do one specific thing: deliver twice the daily return of HIMS stock, reset every single day. If HIMS gains 1% on a trading day, HIMZ aims to gain 2%. If HIMS falls 1%, HIMZ falls 2%. This simple mechanical objective comes with a critical caveat that catches most investors unfamiliar with leveraged funds: over multiple days, weeks, and months, HIMZ’s performance will deviate from simply doubling HIMS’s returns, often sharply.

The reason lies in how daily rebalancing works. At the end of each trading day, the fund must adjust its position to maintain exactly 2X leverage to the next day’s opening. If HIMS rises on day one, HIMZ doubles that move, but then the fund’s leverage ratio shifts because the underlying position is now worth more. To restore exactly 2X leverage, the fund sells some of its HIMS holdings. If HIMS falls on day two, HIMZ doubles that loss, and the fund buys back HIMS positions to restore 2X leverage. Over a pattern of ups and downs, this buy-high-and-sell-low dynamic accumulates losses that have nothing to do with HIMS’s overall trend. This is volatility decay, and it is a permanent feature of any leveraged ETF, especially one that rebalances daily.

A simple example illustrates the effect. Suppose HIMS starts at 100 dollars. On day one it rises 10% to 110, and HIMZ gains 20% to 120. On day two HIMS falls 9% back to 100, and HIMZ falls 18% to 98.4. HIMS is right back where it started, but HIMZ is down 1.6% because of the rebalancing trades. The longer the holding period and the more volatile the underlying stock, the larger this drag becomes. Over a year of price movements, volatility decay can be catastrophic.

HIMZ is designed explicitly for tactical, short-term traders who believe HIMS stock will move in one direction over hours or days and want to amplify that bet. It is not a buy-and-hold investment. A trader using HIMZ in a strong uptrend over a few days might capture the 2X amplification with minimal decay. A trader holding it through a choppy market or a reversal will likely find that decay and the daily reset mechanism have eroded much of the theoretical return. A long-term holder who simply bought HIMZ and waited five years would almost certainly underperform HIMS stock by a substantial margin, even if HIMS itself had a strong return.

Teladoc (ticker HIMS) is a telehealth company that connects patients with healthcare providers through digital platforms. HIMS operates in a fast-growing market but one that is also volatile, with competition, regulatory changes, and shifts in consumer behavior all affecting the stock price significantly. The volatility of HIMS stock is part of what makes a 2X leveraged fund attractive to some traders — HIMS moves enough that 2X amplification can produce large single-day gains on good days. That same volatility makes decay damage especially severe over time.

The fund structure is straightforward. Defiance is the sponsor, and the fund holds HIMS stock using futures contracts, swaps, or direct ownership, rebalanced daily to maintain the 2X target. The expense ratio reflects active management and the costs of daily rebalancing. Trading volume on HIMZ can be thin depending on market conditions, which means a large order to buy or sell might face slippage — the difference between the price you wanted and the price you actually got. During market stress or when HIMS is in a sharp decline, bid-ask spreads can widen substantially.

The real risks are severalfold. Decay is the main one — the fund’s stated objective guarantees daily 2X returns, but only daily. Longer periods introduce decay that erodes value. Liquidity risk matters too. If you need to exit HIMZ in a market crisis, you might not find willing buyers at a fair price. Leverage amplifies losses as well as gains, so a 50% drop in HIMS becomes a 100% loss in HIMZ. During such a decline, the constant rebalancing actually accelerates the damage rather than cushioning it. Finally, there is the risk of using a specialized tool for the wrong purpose — buying HIMZ as a long-term investment rather than as a short-term tactical position is a classic mistake that ends in underperformance.

HIMZ is appropriate only for sophisticated traders with clear short-term directional theses, high conviction that HIMS stock will move substantially in one direction over a discrete time period, and the discipline to exit well before volatility decay becomes severe. It is not a vehicle for investors building a multi-year portfolio, for tax-deferred accounts where rebalancing is taxable, or for anyone uncomfortable with leverage and the possibility of losing more than they expected. Anyone considering HIMZ should read Defiance’s fact sheet and prospectus closely, understand exactly how daily rebalancing works, and stress-test their thesis against a range of price paths for HIMS stock, not just a straight-line move in one direction.